期刊文献+

正交试验优选叶下珠中溶栓成分的提取工艺 被引量:2

Optimization of the Extraction Technology of Thrombolytic Components from Phyllanthus urinaria by Orthogonal Experiment
原文传递
导出
摘要 目的:优选叶下珠中以柯里拉京为主的溶栓成分的提取工艺。方法:以溶剂量、提取时间和提取次数为考察因素,以浸出物和柯里拉京含量的综合评分为指标,采用正交试验优选提取工艺;考察离心法、酸碱法、乙醇沉淀法的除杂质效果。结果:最佳提取工艺为以8倍量30%乙醇为溶剂,回流提取3次,每次2h;90%的乙醇除杂质效果最佳。结论:该工艺简便、稳定,提取物有效成分含量高,可为进一步的开发提供理论依据。 OBJECTIVE: To optimize the extraction technology of thrombolytic components predominantly as corilagin from Phyllanthus urinaria. METHODS: The extraction technology was optimized by orthogonal experiment with solvent amount, extracting time and extracting times as factors, and with the comprehensive score of the yield of extract and corilagin content as indexe. The impurity removing efficacy by centrifugation, acid/ base method or ethanol precipitation was evaluated. RESULTS: The optimal extraction technology was as follows: using 8-fold volume of 30% ethanol as solvent for reflux extraction of 3 times (2 hours/time) . The best impurity- removing efficacy was achieved when 90% ethanol was used for precipitation. CONCLUSION: The extraction technology is simple and stable with high yield of active components, and it provides theoretic basis for the industrial production.
出处 《中国药房》 CAS CSCD 北大核心 2009年第33期2584-2586,共3页 China Pharmacy
基金 广东省中医院中医药科学技术研究专项"名医工作室研究"项目(2007E199)
关键词 叶下珠 柯里拉京 提取 纯化 Phyllanthus urinaria Corilagin Extraction Purification
  • 相关文献

参考文献8

二级参考文献46

共引文献78

同被引文献31

  • 1陈可冀,薛梅,殷惠军.血小板活化与冠状动脉粥样硬化性心脏病和血瘀证的关系[J].首都医科大学学报,2008,29(3):266-269. 被引量:30
  • 2华先平,王琳.血小板活化在动脉粥样硬化中的作用[J].中国微循环,2007,11(3):213-215. 被引量:11
  • 3Jennings L K. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis [J]. Thromb Haemost, 2009, 102(2) : 248-257. 被引量:1
  • 4Willoughby S, Holmes A, Loscalzo J. Platelets and cardiovascular disease[J]. Eur J Cardiovasc Nurs, 2002, 1(4) : 273-288. 被引量:1
  • 5Merten M, Thiagarajan P. P-selectin in arterial thrombosis [ J ]. Z Kardiol, 2004, 93(11): 855-863. 被引量:1
  • 6Htun P, Fateh-Moghadam S, Tomandl B, et al. Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia[J]. Stroke, 2006, 37(9): 2283-2287. 被引量:1
  • 7Schafer A, Bauersachs J. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis[ J]. Curr Vasc Pharmacol, 2008, 6( 1 ) : 52. 被引量:1
  • 8CAPR1E Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [ J ]. Lancet, 1996,348 : 1329. 被引量:1
  • 9Ray WA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clopidogrel and proton -pump inhibitors : a cohort study [ J ]. Ann Intern Med ,2010,152:337. 被引量:1
  • 10Bonello L, Bonello N, Grosdidier C, et al. Unveiling the mysteries of clo- pidogrel metabolism and efficacy [ J ]. Clin Pharmacol Ther, 2011,90 : 774. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部